Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**BMS1 pseudogene 10 (BMS1P10)** is classified as a pseudogene located on chromosome 9q13[1][6][7]. It originates from the BMS1 gene, which encodes a ribosome biogenesis factor involved in ribosomal subunit assembly in eukaryotes. However, as a pseudogene, BMS1P10 does not encode a functional protein and its biological function, if any, is not well-characterized[1]. No evidence supports its role as a therapeutic target, disease biomarker, or involvement in drug interactions[1][6][7].\n\n**Key points:** \n- BMS1P10 is a **pseudogene** and not a protein-coding gene[1][6][7]. \n- It is derived from **BMS1**, a ribosome biogenesis factor, but BMS1P10 itself has **no known biological or therapeutic function**[1]. \n- There is **no evidence** that BMS1P10 contributes to therapeutic mechanisms or is implicated in any disease states, nor is it associated with any clinically relevant drugs[1][6][7].\n\nIf you need data for the functional BMS1 gene (not the pseudogene), that information would differ significantly, as BMS1 codes for a GTPase critical for ribosome assembly and has known biological functions[2][4][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BMS1 pseudogene 10 (BMS1P10).